Start-up Design and Cognitive Decline in Dogs

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter discusses the challenges faced by startups in obtaining high-quality design services and introduces a service called catalog that offers affordable branding and design solutions. It also explores the correlation between intellectual curiosity, health, and longevity, referencing a study on cognitive decline in dogs and the potential societal benefit of increasing people's ability to learn and adapt for a longer period of time.

This Week in Startups is brought to you by…

Fount. Do you want access to the performance protocols that pro athletes and special ops use? With Fount, an elite military operator supercharges your focus, sleep, recovery, and longevity, all powered by your unique data. Want a true edge in work and life? Go to fount.bio/TWIST for $500 off.

LinkedIn Jobs. A business is only as strong as its people, and every hire matters. Go to http://linkedin.com/unicorn to post your first job for free. Terms and conditions apply.

Catalog. Stop wasting time and money with expensive design firms and unreliable freelancers! Get fast, 3-day turnarounds for a flat monthly fee with Catalog! Get $1200 off right now at https://trycatalog.com/twist

Today’s show:

Loyal CEO and Founder Celine Halioua joins Jason to discuss developing drugs that delay dog aging (10:19), lessons learned as a solo founder (49:34), and much more!

Time stamps:

(0:00) Loyal CEO Celine Halioua joins Jason

(1:43) The human dream of achieving life extension

(4:37) Celine’s background

(8:48) Fount - Get $500 off at https://fount.bio/twist

(10:19) Why Celine decided to start with a focus on dogs

(16:43) Wegovy, Ozempic, and the category of drugs that Loyal is developing

(20:44) Breaking down how the drugs work and the consequences of selective breeding

(24:21) LinkedIn Jobs - Post your first job for free at https://linkedin.com/unicorn

(25:36) Stem cell therapy and the placebo effect

(33:29) Environmental factors to consider in drug development

(37:05) The path to commercialization